Personal Image from Westbrook, Connecticut Well, it's been almost a year since I last posted. I took the time to complete my study on...

Like two other new therapies recently approved (Aduhelm & Leqembi), Donanemab will be seeking FDA approval after completing Phase 3...

Photo by Matt Moloney on StockSnap When we think of dementia, we often think of pathological or biomedical models or perspectives of...

Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease...

In the past few months I had the opportunity to interview a few more people with dementia who left work because they were experiencing...

In my completed dissertation pilot study last year, I had the opportunity to interview several people (P1, P2, P3 below) who were...

After what I thought would be a break from the next new experimental dementia drug announcement, along comes lecanemab! Like aduhelm that...

I created this blog in 2021 because I wanted to offer a place where I can objectively share information related to dementia. My current...

A 2018 article in Nature (https://www.nature.com/articles/d41586-018-05719-4) explored the long-held assumption that the amyloid-β...

Late last year, Aduhelm decided to slash the price from $56K down to $28K, in anticipation of Medicare's (Centers for Medicare &...

The Good News...The Social Security Administration announced cost-of-living adjustment (COLA) benefits will increase by 5.9 percent in...

The copy of the article below is taken from the November, 1st 2021 edition of the New Britain Herald. Simple and good advice from an...

I had a wonderful opportunity to share some of my research and personal experiences with dementia with Bobbi and Mike Carducci on their...

On July 29th, the Right Care Alliance (https://rightcarealliance.org/about/) hosted a town hall on Aduhelm, watch here:...

Photo by Marco Verch Professional Photographer The article linked below addresses how older workers/job seekers continue to face age...

Image: http://flickr.com/photo/26728047@N05/4420668601 In today's New Britain Herald, Bristol, Connecticut attorney Daniel Tully...

Overview As a global society, this is the first time we are seeing so many people who are living longer. In 2050, it is expected that...

Family caregiving today is more complex, costly, stressful, and demanding than at any time in human history” (Reinhard, Feinberg, Choula,...

See updates to this post below: Biogen’s new Alzheimer's drug Aduhelm (aducanumab), recently approved by the FDA, is as controversial for...

I admired Ronald Reagan when he was elected to office. I was 16 and very impressionable. Although I liked President Carter too (as any...